Virpax Pharmaceuticals, Inc.
Monday, June 03, 2024
Pain Management
Company Presentation Theater 3
Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications.
Company Website:
https://virpaxpharma.com/
Lead Product in Development:
Probudur- A next generation liposomal bupivacaine formulation that has demonstrated 96 hours pain control after administering a single injection at the wound site in animal studies.
Number Of Unlicensed Products (For Which You Are Seeking Partners):
5
Exchange
NASDAQ
Ticker
VRPX
Company HQ City
Berwyn
Company HQ State
PA
Company HQ Country
United States
CEO/Top Company Official
Gerald W. Bruce
Development Phase of Primary Product
Pre-Clinical
Primary Speaker
)
)
)
)
)
)
){kind=logo}
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())